Metabolites (Oct 2023)

Involvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema

  • Mauro Vasella,
  • Stefan Wolf,
  • Eamon C. Francis,
  • Gerrit Grieb,
  • Pablo Pfister,
  • Gregory Reid,
  • Jürgen Bernhagen,
  • Nicole Lindenblatt,
  • Epameinondas Gousopoulos,
  • Bong-Sung Kim

DOI
https://doi.org/10.3390/metabo13101105
Journal volume & issue
Vol. 13, no. 10
p. 1105

Abstract

Read online

Lipedema is a chronic disorder that mainly affects women. It is often misdiagnosed, and its etiology remains unknown. Recent research indicates an accumulation of macrophages and a shift in macrophage polarization in lipedema. One known protein superfamily that contributes to macrophage accumulation and polarization is the macrophage migration inhibitory factor (MIF) family. MIF-1 and MIF-2 are ubiquitously expressed and also regulate inflammatory processes in adipose tissue. In this study, the expression of MIF-1, MIF-2 and CD74—a common receptor for both cytokines—was analyzed in tissue samples of 11 lipedema and 11 BMI-matched, age-matched and anatomically matched control patients using qPCR and immunohistochemistry (IHC). The mRNA expression of MIF-1 (mean 1.256; SD 0.303; p = 0.0485) and CD74 (mean 1.514; SD 0.397; p = 0.0097) were significantly elevated in lipedema patients, while MIF-2 expression was unaffected (mean 1.004; SD 0.358; p = 0.9718). The IHC analysis corroborated the results for CD74 expression on a cellular level. In conclusion, our results provide first evidence for a potential involvement of the MIF family, presumably via the MIF-1-CD74 axis, in lipedema.

Keywords